- Report
- May 2026
- 307 Pages
Global
From €2222EUR$2,500USD£1,904GBP
- Report
- February 2026
- 250 Pages
Global
From €3990EUR$4,490USD£3,419GBP
- Report
- December 2025
- 210 Pages
Global
From €5287EUR$5,950USD£4,531GBP
- Report
- October 2025
- 120 Pages
Global
From €5287EUR$5,950USD£4,531GBP
- Report
- August 2026
- 199 Pages
Global
From €3150EUR$3,545USD£2,700GBP
€3500EUR$3,939USD£3,000GBP
- Report
- February 2026
- 250 Pages
Global
From €3990EUR$4,490USD£3,419GBP
- Report
- February 2026
- 250 Pages
Global
From €3990EUR$4,490USD£3,419GBP
- Report
- February 2026
- 250 Pages
Global
From €3990EUR$4,490USD£3,419GBP
- Report
- February 2026
- 250 Pages
Global
From €3990EUR$4,490USD£3,419GBP
- Report
- February 2026
- 250 Pages
Global
From €3990EUR$4,490USD£3,419GBP
- Report
- February 2026
- 250 Pages
Global
From €3990EUR$4,490USD£3,419GBP
- Report
- February 2026
- 250 Pages
Global
From €3990EUR$4,490USD£3,419GBP
- Report
- February 2026
- 250 Pages
Global
From €3990EUR$4,490USD£3,419GBP
- Report
- August 2026
- 373 Pages
Global
From €5198EUR$5,850USD£4,455GBP
- Report
- August 2026
- 282 Pages
Global
From €5198EUR$5,850USD£4,455GBP
- Report
- February 2026
- 200 Pages
Global
From €4439EUR$4,995USD£3,804GBP
- Report
- July 2026
- 160 Pages
Global
From €2950EUR$3,320USD£2,528GBP
€3688EUR$4,150USD£3,160GBP
- Report
- January 2026
- 160 Pages
Global
From €2808EUR$3,160USD£2,406GBP
€3510EUR$3,950USD£3,008GBP
- Report
- January 2025
- 456 Pages
Global
From €4399EUR$4,950USD£3,769GBP
- Report
- June 2023
- 186 Pages
Global
From €4132EUR$4,650USD£3,541GBP

Kidney cancer, also known as renal cancer, is a type of cancer that originates in the kidneys. It is one of the most common types of cancer in adults, and is typically diagnosed in individuals over the age of 50. Symptoms of kidney cancer can include blood in the urine, pain in the side or lower back, and a lump in the abdomen. Treatment options for kidney cancer include surgery, radiation therapy, and chemotherapy.
In the oncology market, kidney cancer is a major area of focus for drug development. Pharmaceutical companies are researching and developing new treatments to improve outcomes for patients with kidney cancer. These treatments include targeted therapies, immunotherapies, and combination therapies.
Some companies in the kidney cancer market include Bristol-Myers Squibb, Merck, Pfizer, AstraZeneca, and Novartis. Show Less Read more